On Thursday, October 25, 2018, Attorney General Andy Beshear filed suit against Pennsylvania-based pharmaceutical manufacturer Teva for allegedly promoting its fentanyl-based cancer drugs for “off-label” use in Kentucky, which allegedly contributed to the state’s addiction outbreak. The lawsuit, filed in Fayette Circuit Court, claims Teva persuaded physicians to prescribe its drugs, Actiq and Fentora, to treat chronic pain despite drugs being approved solely for breakthrough pain in cancer patients. The lawsuit alleges Teva’s sales force targeted general practitioners.